Centanafadine

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Centanafadine
Centanafadine.svg
Systematic (IUPAC) name
(1R,5S)-1-naphthalen-2-yl-3-azabicyclo[3.1.0]hexane
Clinical data
Legal status
  • Investigational New Drug
Identifiers
CAS Number 924012-43-1
PubChem CID: 16095349
ChemSpider 17253639
Chemical data
Formula C15H15N
Molecular mass 209.28 g/mol
  • C1=C(C=CC2=CC=CC=C12)[C@@]34C[C@@H]3CNC4
  • InChI=1S/C15H15N/c1-2-4-12-7-13(6-5-11(12)3-1)15-8-14(15)9-16-10-15/h1-7,14,16H,8-10H2/t14-,15+/m1/s1
  • Key:HKHCSWPSUSWGLI-CABCVRRESA-N

Centanafadine (INN) (former developmental code name EB-1020) is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development by Neurovance in collaboration with Euthymics Bioscience as a treatment for attention deficit hyperactivity disorder (ADHD) that inhibits the reuptake of norepinephrine, dopamine and serotonin with a ratio of 1:6:14, respectively.[1][2][3] As of August 2015, it is in phase II clinical trials.[1]

See also

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. Lua error in package.lua at line 80: module 'strict' not found.

External links


<templatestyles src="Asbox/styles.css"></templatestyles>